Pharmacology, Part 4: Nuclear Cardiology

Nuclear cardiology, Part IV: Viability.

After reading Part IV of this series of nuclear cardiology articles, the reader should be able to describe: (a) the differences between SPECT and PET techniques; (b) the various radiopharmaceuticals and imaging protocols used for detecting viability with SPECT; (c) the different radiopharmaceuticals and imaging protocols used for detecting viability with PET; and (d) the imaging patterns observ...

Nuclear cardiology in Iran in 2002 [Persian]

Aim: Few nuclear cardiology surveys were published in the literature, mostly from developed countries. The aim of this study is to perform a nuclear cardiology survey in Iran. This may lead to better decision making and programming. Methods and Materials: A questionnaire was sent by mail or e-mail to all nuclear medicine centers in Iran asking for details of nuclear cardiology practice in...

Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusion.

OBJECTIVE After reading Part III of this series of nuclear cardiology articles, the technologist should be able to: (a) compare and contrast radiopharmaceuticals used for myocardial perfusion imaging; (b) describe imaging protocols used for detecting coronary artery disease; and (c) describe imaging patterns seen following reconstruction of myocardial images.

COCATS 4 Task Force 6: Training in Nuclear Cardiology : Endorsed by the American Society of Nuclear Cardiology.

The Writing Committee was selected to represent the American College of Cardiology (ACC) and the American Society of Nuclear Cardiology (ASNC) and included a cardiovascular training program director; a nuclear cardiology training program director; earlycareer experts; highly experienced specialists in both academic and community-based practice settings; and physicians experienced in defining an...

International perspectives on nuclear cardiology.